To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Initial Surgery vs Corticosteroid Injection for Carpal Tunnel Syndrome

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2025

Initial Surgery vs Corticosteroid Injection for Carpal Tunnel Syndrome

Vol: 307| Issue: 10| Number:13| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Surgery versus corticosteroid injection for carpal tunnel syndrome (DISTRICTS): an open-label, multicentre, randomised controlled trial.

Lancet . 2025 Jun 14;405(10495):2153-2163.

Contributing Authors:
WAC Palmbergen R Beekman AM Heeren BFL van Nuenen TWH Alleman E Verstraete K Jellema WIM Verhagen LH Visser GCW de Ruiter D van de Beek CAJM de Borgie JA Bogaards RMA de Bie C Verhamme

Synopsis

Nine hundred fourty one patients with carpal tunnel syndrome (CTS) were randomized to receive initial surgical decompression (n=470) or initial corticosteroid injection (n=471); further interventions were allowed in both arms as needed. The primary outcome was recovery at 18 months (CTS-6 <8). Secondary outcomes included time to recovery, serial CTS-6, upper-limb function (QuickDASH), palmar pain ...

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue